Form 4: Xylem Inc. VP, Controller & CAO Geri-Michelle McShane Reports Stock Transactions
SEC Form 4
Geri-Michelle McShane, VP, Controller & CAO of Xylem Inc., reported the exercise of stock options and subsequent sale of shares on June 10, 2024.
Summary
- On June 10, 2024, Geri-Michelle McShane, VP, Controller & CAO of Xylem Inc., executed transactions involving Xylem's common stock.
- McShane exercised non-qualified stock options to acquire 1,019 shares at $75.18 and 747 shares at $74.07.
- Following the option exercises, McShane sold 2,278 shares at a weighted average price of $138.63, with prices ranging from $138.62 to $138.65.
- After these transactions, McShane directly owns 3,536 shares of Xylem Inc. common stock.
- McShane also directly owns 1,019 non-qualified stock options (Right to Buy) at $75.18 and 747 non-qualified stock options (Right to Buy) at $74.07.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of stock transactions. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, which are common for executives who receive stock options as part of their compensation. These filings are closely watched by investors for insights into management's perspective on the company's stock.
Comparison to Industry Standards
- Executive compensation packages often include stock options to align management's interests with those of shareholders.
- The vesting schedules and exercise prices of these options are typical for the industry.
- Similar transactions are regularly reported by executives at comparable companies like Danaher (DHR) and Roper Technologies (ROP).
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the overall effect is likely minimal.
Key Dates
| Date | Description |
|---|---|
| 2018-02-21 | Date of option grant that vested one third on February 21, 2019, February 21, 2020, and February 21, 2021. |
| 2019-02-20 | Date of option grant that vested one third on February 20, 2020, February 20, 2021, and February 20, 2022. |
| 2023-11-15 | Date of Power of Attorney document. |
| 2024-06-10 | Date of stock option exercise and sale of shares. |
| 2024-06-11 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.